Validation of the new FIGO staging system (2009) for vulvar cancer in the Chinese population

Gynecologic Oncology
Jiajia LiHuijuan Yang

Abstract

A new FIGO staging system for vulvar cancer was issued in 2009. The aim of this study was to identify its value in estimating the outcome of patients with vulvar squamous cell carcinoma (VSCC) in the Chinese population. A total of 184 patients who underwent radical surgery for VSCC were recruited. Their medical records and pathology slides were reviewed. Disease reclassification was conducted according to the FIGO staging system (2009). The primary outcomes were cause-specific survival (CSS), relapse-free survival (RFS) and overall survival (OS). A total of 76 patients (41.3%) were downstaged and no patients were upstaged in the new FIGO staging system (2009). The stage distribution was as follows: stage I (99), stage II (13), stage III (65) and stage IV (7). According to CSS, the patients were classified into 4 groups: stage IA (group 1), stage IB/II/IIIA (group 2), stage IIIB (group 3), and stage IIIC/IV (group 4) (5-year CSS: 100%, 85%, 34.6% and 0%, respectively). The 5-year CSS was similar among the patients with stage IB, II and IIIA carcinomas (84.4%, 84.6% and 84.8%, respectively, p=0.986), whereas, significant decline of the CSS was found with increased substages of stages IIIA, IIIB and IIIC (84.8%, 34.6%, and 0 respe...Continue Reading

References

Feb 1, 1993·Gynecologic Oncology·B PiuraJ Monaghan
Jan 1, 1997·Gynecologic and Obstetric Investigation·B Smyczek-GargyaJ Dietl
Sep 14, 2000·Gynecologic Oncology·A RodolakisS Michalas
Dec 7, 2002·Obstetrics and Gynecology·Roman RouzierBernard Jean Paniel
Mar 2, 2006·Obstetrics and Gynecology·Frederick B Stehman, Katherine Y Look
Jan 18, 2008·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Franco OdicinoWilliam T Creasman
Feb 19, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ate G J Van der ZeeWim J Sluiter
Mar 31, 2009·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Neville F Hacker
Apr 16, 2009·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Sergio Pecorelli
Sep 30, 2010·Gynecologic Oncology·S van der SteenJ A de Hullu
Mar 1, 2012·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Jason TanAndreas Obermair
Jul 4, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles F LevenbackCornelia L Trimble
Oct 4, 2012·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Neville F HackerJacobus van der Velden
Dec 25, 2012·Archives of Gynecology and Obstetrics·Jacek J SznurkowskiJanusz Emerich
Jan 9, 2014·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal

❮ Previous
Next ❯

Citations

Mar 10, 2016·Current Medical Research and Opinion·Jinhong Zhou, Guoping Shan
Sep 27, 2018·Obstetrics and Gynecology International·Panida MeelapkijOrthai Baisai
Apr 28, 2020·Gynécologie, Obstétrique, Fertilité & Sénologie·E SerreUNKNOWN Groupe de Recherche FRANCOGYN

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.